BOSTON, March 14, 2025 /PRNewswire/ -- Life Molecular Imaging (LMI) and St. Teresa's Hospital are pleased to announce that Florbetaben (18F) Injection (brand name: Neuraceq ®) will be available in ...

Celltrion today announced the U.S. launch of STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), following ...

Late-stage data also showed that Johnson & Johnson’s icotrokinra was superior to Bristol Myers Squibb’s Sotyktu at clearing ...

MANAH: The Oman Across Ages Museum marked the launch of its new visual identity on March 13, celebrating a symbol of heritage ...

Minister for Veterans and People Al Carns is among the team of ex-Special Forces soldiers aiming to climb Everest in a record ...

South Korea’s Celltrion (Kosdaq: 068270) has announced the US launch of Steqeyma (ustekinumab-stba), a biosimilar to Stelara ...

Agricultural technology company Syngenta has hosted civic dignitaries and invited guests at the opening of its new life sciences advanced manufacturing facility in Huddersfield.

Johnson & Johnson’s once-daily oral peptide has bested Bristol Myers Squibb’s reigning oral psoriasis med Sotyktu in a ...

Celltrion today announced the U.S. launch of STEQEYMA��(ustekinumab-stba), a biosimilar to STELARA� (ustekinumab), following approval by the U.S. Food and Drug Administration (FDA) in December 2024.

Positive results were reported for Johnson & Johnson's psoriasis drug during.a late-breaking research session today at the ...

Texas A&M students have made history by having one of their names on a plaque that landed on the moon as part of Firefly ...